Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 8 | 2022 | 240 | 1.580 |
Why?
|
| Catheter Ablation | 12 | 2023 | 624 | 1.500 |
Why?
|
| Atrial Fibrillation | 14 | 2023 | 721 | 1.200 |
Why?
|
| Defibrillators, Implantable | 4 | 2020 | 223 | 0.710 |
Why?
|
| Atrial Appendage | 4 | 2021 | 55 | 0.510 |
Why?
|
| Ethanol | 2 | 2013 | 264 | 0.460 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 36 | 0.450 |
Why?
|
| Fluoroscopy | 2 | 2013 | 232 | 0.450 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2023 | 226 | 0.440 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2010 | 61 | 0.370 |
Why?
|
| Robotics | 2 | 2012 | 359 | 0.360 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2010 | 160 | 0.350 |
Why?
|
| Angioplasty, Balloon | 1 | 2010 | 183 | 0.340 |
Why?
|
| Pulmonary Veins | 3 | 2023 | 175 | 0.340 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1016 | 0.330 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 927 | 0.320 |
Why?
|
| Electrocardiography | 5 | 2022 | 1145 | 0.320 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2020 | 254 | 0.300 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 498 | 0.280 |
Why?
|
| Electric Countershock | 2 | 2020 | 72 | 0.280 |
Why?
|
| Lung Transplantation | 1 | 2010 | 363 | 0.280 |
Why?
|
| Nanoparticles | 2 | 2022 | 556 | 0.260 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 3 | 2020 | 69 | 0.250 |
Why?
|
| Nicorandil | 1 | 2004 | 1 | 0.250 |
Why?
|
| Long QT Syndrome | 2 | 2004 | 91 | 0.240 |
Why?
|
| Heart Atria | 4 | 2016 | 352 | 0.240 |
Why?
|
| Stents | 1 | 2010 | 1099 | 0.240 |
Why?
|
| Bundle-Branch Block | 1 | 2004 | 43 | 0.230 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 222 | 0.220 |
Why?
|
| Heart Failure | 2 | 2014 | 2521 | 0.210 |
Why?
|
| Thrombosis | 2 | 2021 | 782 | 0.210 |
Why?
|
| Ventricular Premature Complexes | 1 | 2022 | 16 | 0.210 |
Why?
|
| Stroke | 2 | 2023 | 1150 | 0.200 |
Why?
|
| Action Potentials | 1 | 2004 | 562 | 0.200 |
Why?
|
| Septal Occluder Device | 1 | 2021 | 49 | 0.190 |
Why?
|
| Ventricular Septum | 1 | 2020 | 20 | 0.180 |
Why?
|
| Warfarin | 2 | 2023 | 152 | 0.170 |
Why?
|
| Coronary Sinus | 1 | 2019 | 17 | 0.170 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 34 | 0.150 |
Why?
|
| Heart Conduction System | 3 | 2014 | 165 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 686 | 0.140 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 262 | 0.140 |
Why?
|
| Registries | 2 | 2021 | 2173 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 304 | 0.130 |
Why?
|
| Treatment Outcome | 12 | 2023 | 32898 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 137 | 0.130 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 216 | 0.130 |
Why?
|
| Myocardium | 2 | 2022 | 1294 | 0.130 |
Why?
|
| Anticoagulants | 2 | 2023 | 788 | 0.130 |
Why?
|
| Heart | 2 | 2016 | 1225 | 0.120 |
Why?
|
| Spinal Cord Stimulation | 1 | 2014 | 27 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2019 | 667 | 0.120 |
Why?
|
| Recurrence | 2 | 2013 | 4760 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 192 | 0.110 |
Why?
|
| Heart Block | 1 | 2012 | 48 | 0.110 |
Why?
|
| Syncope | 1 | 2012 | 65 | 0.100 |
Why?
|
| Heart Ventricles | 3 | 2022 | 848 | 0.100 |
Why?
|
| Dogs | 1 | 2013 | 1153 | 0.100 |
Why?
|
| Temperature | 2 | 2023 | 508 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 245 | 0.100 |
Why?
|
| Humans | 26 | 2023 | 261808 | 0.100 |
Why?
|
| Aged | 13 | 2023 | 70174 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2016 | 898 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 235 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 255 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2401 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 310 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 1381 | 0.090 |
Why?
|
| Male | 14 | 2021 | 123091 | 0.080 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 371 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2021 | 5543 | 0.080 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2021 | 304 | 0.070 |
Why?
|
| Calcium | 1 | 2014 | 1548 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 1017 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2023 | 12889 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 601 | 0.070 |
Why?
|
| Patient Safety | 1 | 2012 | 651 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 1906 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2005 | 101 | 0.060 |
Why?
|
| Bundle of His | 1 | 2004 | 9 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 1234 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 1301 | 0.060 |
Why?
|
| Veins | 1 | 2004 | 157 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 2196 | 0.050 |
Why?
|
| Catheters | 1 | 2023 | 129 | 0.050 |
Why?
|
| Hypertension | 1 | 2012 | 1505 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2004 | 237 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1360 | 0.050 |
Why?
|
| Female | 11 | 2021 | 142054 | 0.050 |
Why?
|
| Animals | 5 | 2017 | 59533 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 649 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 713 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 573 | 0.040 |
Why?
|
| Risk Factors | 4 | 2021 | 17537 | 0.040 |
Why?
|
| Time Factors | 3 | 2021 | 12941 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 14889 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2017 | 61 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2023 | 29917 | 0.040 |
Why?
|
| Boron Compounds | 1 | 2017 | 59 | 0.040 |
Why?
|
| Middle Aged | 8 | 2023 | 86310 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 477 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 434 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2016 | 72 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 960 | 0.030 |
Why?
|
| Atrial Function | 2 | 2005 | 18 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 5366 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2021 | 735 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 458 | 0.030 |
Why?
|
| Vascular Calcification | 1 | 2015 | 51 | 0.030 |
Why?
|
| Multidetector Computed Tomography | 1 | 2015 | 151 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 193 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2014 | 188 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 462 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2014 | 185 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 69 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2012 | 77 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 37972 | 0.020 |
Why?
|
| Incidence | 1 | 2021 | 5673 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 428 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 4535 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1475 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 2295 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 6689 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 7569 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 1207 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 2595 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 783 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12231 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 2797 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 3262 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 4893 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 2597 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 4140 | 0.020 |
Why?
|
| Los Angeles | 1 | 2005 | 31 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6022 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2005 | 31 | 0.020 |
Why?
|
| Adult | 3 | 2012 | 78030 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 64 | 0.020 |
Why?
|
| Phlebography | 1 | 2004 | 76 | 0.020 |
Why?
|
| Tachycardia | 1 | 2004 | 70 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2004 | 109 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 736 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2012 | 1306 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 143 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 6872 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2004 | 176 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 190 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2004 | 127 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 6916 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 444 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2004 | 602 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 7226 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 1177 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 5687 | 0.010 |
Why?
|
| Research Design | 1 | 2005 | 1546 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 4326 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 4972 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 34439 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 7718 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 21733 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 31253 | 0.000 |
Why?
|
| Child | 1 | 2004 | 29130 | 0.000 |
Why?
|